Impact of Beta-Blocker Initiation Timing on Mortality Risk in Patients With Diabetes Mellitus Undergoing Noncardiac Surgery: A Nationwide Population-Based Cohort Study [Epidemiology]

ConclusionsThe use of cardioprotective beta‐blockers for>30 days before surgery was associated with reduced mortality risk, whereas short‐term use of beta‐blockers was not associated with differences in mortality in patients with diabetes mellitus.

Source: JAHA:Journal of the American Heart Association - January 10, 2017 Category: Cardiology Authors: Chen, R.-J., Chu, H., Tsai, L.-W. Tags: Diabetes, Type 2, Epidemiology Original Research Source Type: research